Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013

5th Ocular Diseases & Drug Development

21 Mar 2013 - 22 Mar 2013 - San Francisco, USA

Bookmark and Share

To help promote the discovery of ocular disease and drug development, GTC is bringing together leading scientists, researchers, and experts to discuss and collaborate on the latest research and discovery, safety assessment, and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, DME, uveitis and other eye diseases at the 5th Ocular Diseases and Drug Development Conference (March 21-22, 2013 in San Francisco, CA). The last annual conference was well attended with representation from key R&D folks from GSK, Pfizer, B&L, Allergan, Alcon and this year is showing promise to be even bigger and better.

The conference agenda is currently in development. The conference will focus on the following sessions: 

Session: Novel Targets, Developments and Technologies

Session: Models of Ocular Diseases and Clinical Relevance

Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments

Session: Clinical Development Advances & Updates 

Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development

Panel Discussion: Safety and Regulatory in Ocular Development

We are in the process of trying to get Wiley Chambers over to the conference to give a presentation and Samir Patel at Ophthotech is confirmed to give a keynote presentation at the conference. Please check back in November for more details. 

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or for more information.

Further information
Scientific News
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Substance Can Potentially Postpone Aging
Researchers bridge the gap between two main aging theories - repairs to the DNA and poor functioning mitochondria.
Untangling Cause Of Memory Loss In Neurodegenerative Diseases
NIH-funded mouse study identifies a possible therapeutic target for a family of disorders.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.
Preventing Alzheimer's in Mice
Researchers have prevented the Alzheimer’s development in mice by using a virus delivery system to transport a specific gene into the brain.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos